Ibuprofen Mercury Pharma Group (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are required for the synthesis of prostaglandins. Lower prostaglandin levels decrease the sensitisation of pain receptors and limit the inflammatory cascade, providing analgesic and anti‑inflammatory effects at the site of application.

The appropriate dose and frequency are determined by the prescribing healthcare professional based on the patient’s condition, age, and response. The prescriber will specify the amount of product to apply and how often it should be used.

Safety data for topical ibuprofen in pregnancy and lactation are limited. It should be used only if clearly needed and after consultation with a qualified healthcare provider, who can weigh potential benefits against any possible risks to the mother and infant.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other topical NSAIDs such as diclofenac gel, ibuprofen offers a similar mechanism of COX inhibition but may differ in skin absorption profile, potency and patient tolerance. Choice between products often depends on clinician preference, specific formulation characteristics and individual patient response.

Store the product at ambient temperature, ideally below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme temperatures. Keep the container tightly closed when not in use to maintain product stability.

The product is applied externally to clean, dry, intact skin. A thin layer is spread over the affected area and gently massaged until absorbed. Do not cover the area with occlusive dressings unless directed by a healthcare professional.

Serious risks include allergic contact dermatitis, systemic NSAID toxicity such as gastrointestinal bleeding, and renal impairment, especially in patients with pre‑existing kidney disease or those taking interacting medications. Any signs of severe rash, swelling, stomach pain or reduced urine output should prompt immediate medical attention.

Individuals with a known hypersensitivity to ibuprofen, other NSAIDs, or any component of the formulation should avoid use. It is also contraindicated on broken or infected skin, in children under 12 years without medical advice, and in patients with certain cardiovascular, renal or gastrointestinal conditions unless approved by a clinician.